Recombinant Human Cancer/testis antigen 2 (CTAG2)

ACP09374

Number

Order Exclusive Products Now

Request a Quote

High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications

Cat.No	ACP09374	Target Name	CTAG2
Form	Lyophilized powder	Expression System	Custom Production. Please inquire and provide the desire expression system.
Expression Range	1-210aa	Mol Weight	23.1kDa
Protein Length	Full length	Purity	Greater than 90% as determined by SDS-PAGE.
Storage Buffer	5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information

Target Species	Human	Uniprot ID	O75638

Background Information

Uniprot Id

O75638
Target Species

Human
Target Name

CTAG2
Target Full Name

Cancer/testis antigen 2
Target Research Area

Cancer
Target Synonyms

Autoimmunogenic cancer/testis antigen NY ESO 2; Autoimmunogenic cancer/testis antigen NY-ESO-2; CAMEL; Cancer/testis antigen 2; Cancer/testis antigen 6.2; CT 2; CT2; CT6.2; CTAG 2; CTAG2; CTAG2_HUMAN; CTL recognized antigen on melanoma; ESO 2; ESO2; L antigen family member 1; LAGE 1; LAGE 1a protein; LAGE 2b; LAGE-1; LAGE1; LAGE2b; MGC138724; MGC3803

Inquire Recombinant Human Cancer/testis antigen 2 (CTAG2) Now

Full Name *

Business Email Address *

Phone

Products/Services

Catalog Number

Quantity (μg, mg, g, μl, ml, L, kit)

Address

Project Description

AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Submit

Recombinant Human Cancer/testis antigen 2 (CTAG2)

Specifications

Immunogen Information

Inquire Recombinant Human Cancer/testis antigen 2 (CTAG2) Now

Related Products